Everolimus in Treating Patients With Progressive or Recurrent, Unresectable, or Metastatic Thyroid Cancer

The recruitment status of this study is unknown because the information has not been verified recently.

Verified May 2010 by National Cancer Institute (NCI).
Recruitment status was Recruiting

Study NCT01118065 Information provided by National Cancer Institute (NCI)

First Received on May 5, 2010. Last Updated on May 12, 2010 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Head and Neck Cancer

Additional conditions recognized in this trial

More general conditions related to this trial

Interventions listed in this trial

everolimus

Additional drug interventions recognized in this trial

Sirolimus

More general drug interventions related to this trial

Sponsors listed in this trial